169th Meeting of the National Cancer Advisory Board - Meeting Agenda

Thursday, September 4, 2025

Time: 9:00 AM to 4:00 PM EDT
Location: National Cancer Institute, Shady Grove Campus, Terrace Level, Conference Room TE 406
NIH Videocast: https://videocast.nih.gov/watch=56921

Agenda - Open Session
Time	Presentation Topic	Presenter
9:00 am - 9:05 am	Call to Order and Opening Remarks Consideration of Meeting Summaries: 10 June 2025 NCAB Meeting (previously scheduled for the 13 February meeting) 10 June 2025 NCAB Meeting (regular meeting) Conflict of Interest Future Meeting Dates: Confirmed: December 1-3, 2025 (Monday, Tuesday, Wednesday) February 12, 2026 - Virtual (Thursday) June 10-11, 2026 (Wednesday, Thursday) September 2-3, 2026 (Wednesday, Thursday) December 1-2, 2026 (Tuesday, Wednesday)	Dr. Carpten
9:05 am - 9:30 am	NIH Director's Remarks	Dr. Bhattacharya
9:30 am - 10:05 am	NCI Principal Deputy Director's Report	Dr. Lowy
10:05 am - 10:35 am	Budget Update	Dr. Lowy & Mr. Ricks
10:35 am - 10:45 am	Break
RFA/Coop. Agr. /Single Source** Concepts - Re-issue
10:45 am - 11:05 am	Division of Cancer Biology Metastasis Research Network (MetNet) (Re-issue RFA/Coop. Agr./U54)	Dr. Watson
11:05 am - 11:25 am	Division of Cancer Control and Population Sciences Carcinogen Hazard Assessment Monographs Program (CHAMP) (Re-issue RFA/R01)	Dr. Lam
11:25 am - 11:45 am	Division of Cancer Treatment and Diagnosis Biospecimen Banks to Support NCI NCTN and EET Clinical Trials (Re-issue RFA/Coop. Agr./U24/ Single Source)	Dr. Makhlouf
11:45 am - 12:05 pm	Division of Cancer Treatment and Diagnosis Glioblastoma Therapeutics Network (GTN) (Re-issue RFA/Coop. Agr./U19)	Dr. Forry
12:05 pm - 1:05 pm	Lunch
1:05 pm - 1:25 pm	Division of Cancer Treatment and Diagnosis Childhood Cancer Survivor Study (CCSS) (Re-issue RFA/Coop. Agr./U24/ Single Source)	Dr. Seibel
1:25 pm – 1:30 pm	Program Announcement with special receipt, referral and/or review (PAR) (en bloc)	Dr. Srinivas
1:30 pm - 1:45 pm	Ongoing and New Business Future Agenda Items Informational Items	Dr. Carpten
1:45 pm - 2:00 pm	Break and Adjournment of Open Session

Agenda - Closed Session
Time	Presentation Topic	Presenter
2:00 pm - 4:00 pm	This portion of the meeting is being closed to the public in accordance with the Provisions set forth in Sections 552b(c) (4), 552b(c) (6). Title 5 U.S. Code and 10(d) of The Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2). Grants Review Discussion of Personnel and Proprietary Issues
4:00 pm	Adjournment

* Request for Application (RFA); ** Cooperative Agreement (Coop. Agr.); ***Single Source

Speakers

Jay Bhattacharya, M.D., Ph.D.
Director
National Institutes of Health
Bethesda, MD

Dr. Suzanne Forry Ph.D.
Program Director
Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
National Institutes of Health
Bethesda, MD

Tram Kim Lam, Ph.D., M.P.H.
Chief
Environmental Epidemiology Branch
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
Bethesda, MD

Douglas Lowy, M.D.
Principal Deputy Director
National Cancer Institute
National Institutes of Health
Bethesda, MD

Hala R. Makhlouf, M.D., Ph.D.
Acting Chief
Pathology Investigation & Resources Branch
Division of Cancer Treatment and Diagnosis
National Cancer Institute
National Institute of Health
Bethesda, MD

Mr. Weston Ricks, M.B.A.
Director
Office of Budget and Finance
National Cancer Institute
National Institutes of Health
Bethesda, MD

Dr. Nita Seibel M.D.
Head
Pediatric Solid Tumors
Clinical Investigations Branch
Division of Cancer Treatment and Diagnosis
National Cancer Institute
National Institutes of Health
Bethesda, MD

Joanna Watson, Ph.D.
Chief
Tumor Metastasis Branch
Division of Cancer Biology
National Cancer Institute
National Institutes of Health
Bethesda, MD